Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: PHARMARON, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-13 to 2024-09-12
Current total value of award: $39060
Description: EVALUATING ADME OF COMPOUNDS FROM DYSTONIA PROJECT